Cell contact-dependent activation ,of α3β1 integrin modulates endothelial cell responses to thrombospondin-1

Molecular Biology of the Cell

Volumn 11, Issue 9, 2000, Pages 2885-2900

  Chandrasekaran, L ^a   He, C Z ^a   Al Barazi, H ^a   Krutzsch, H C ^a   Iruela Arispe, M L ^a   Roberts, D D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CD36 ANTIGEN; INTEGRIN; NERVE CELL ADHESION MOLECULE; PROTEOGLYCAN; RECEPTOR; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL CONTACT; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0034492232     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.9.2885     Document Type: Article

References (82)

1. The interaction of plasma fibronectin with fibroblastic cells in suspension
2. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions
3. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels
4. Specific inhibition of endothelial cell proliferation by thrombospondin
5. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins
6. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide
7. Thrombospondins: Structure and regulation of expression
8. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
9. Requirement of vascular integrin αvβ3 for angiogenesis
10. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin
11. Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum
12. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells
13. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by α3β1 integrin and regulated by insulin-like growth factor-1 and CD98
14. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism
15. Thrombospondin-1 is a major activator of TGF-β1 in vivo
16. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
17. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
18. Alpha 6.beta 1 integrin (laminin receptor) is down-regulated by tumor necrosis factor alpha and interleukin-1 beta in human endothelial cells
19. Identification of integrin α3β1 as a neuronal thrombospondin receptor mediating neurite outgrowth
20. Vascular endothelial (VE)-cadherin: Only an intercellular glue?
21. Distinct and overlapping ligand specificities of the α3Aβ1 and α6Aβ1 integrins: Recognition of laminin isoforms
22. Complementation of dominant suppression implicates CD98 in integrin activation
23. Angiogenesis in cancer, vascular, rheumatoid and other disease
24. Thrombospondin modulates αvβ3 function through integrin-associated protein
25. A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin
26. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1
27. A cell signal pathway involving laminin-5, α3β1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation
28. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
29. Anti-proliferative and anti-tumor activities of D-reverse peptide mimetics derived from the second type-1 repeat of thrombospondin-1
30. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells
31. Thrombospondin-1 promotes alpha3beta1 integrin-mediated adhesion and neurite-like outgrowth and inhibits proliferation of small cell lung carcinoma cells
32. Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1
33. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion
34. Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin
35. Vascular-endothelial cadherin (CD144)- but not PECAM-1 (CD31)-based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer
36. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
37. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: Cell distribution and antigenic relation to components on resting cells and T cell lines
38. Vascular-endothelial-cadherin modulates endothelial monolayer permeability
39. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1
40. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
41. Inhibition of angiogenesis by thrombspondin-1 is mediated by two independent regions within the type 1 repeats
42. Corneal endothelial wound closure in vitro
43. Role of thrombospondin-1-derived peptide, 4N1K, in FGF2-induced angiogenesis
44. Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists
45. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors
46. Identification of an α3β1 integrin recognition sequence in thrombospondin-1
47. Thrombospondin inhibits adhesion of endothelial cells
48. Cell attachment to thrombospondin: The role of ARG-GLY-ASP, calcium, and integrin receptors
49. The release of heparin binding peptides from platelet thrombospondin by proteolytic action of thrombin, plasmin and trypsin
50. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation
51. Role of thrombospondin in the adhesion of human endothelial cells in primary culture
52. Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers
53. Regulation of thrombospondin secretion by cells in culture
54. Thrombospondin: Biosynthesis, distribution, and changes associated with wound repair in corneal endothelium
55. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity
56. Thrombospondin modulates focal adhesions in endothelial cells
57. Matrix-bound thrombospondin promotes angiogenesis in vitro
58. Endothelial cell mitogenesis induced by LPA: Inhibition by thrombospondin-1 and thrombospondin-2
59. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
60. The pathophysiology of angiogenesis
61. Expression of thrombospondins by endothelial cells: Injury is correlated with TSP-1
62. Transforming growth factor beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
63. Regulation of tumor growth and metastasis by thrombospondin-1
64. Purification of thrombospondin from human platelets
65. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism
66. Control of cell cycle progression by fibronectin matrix architecture
67. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis
68. Cooperation between thrombospondin-1 type 1 repeat peptides and integrin αvβ ligands to promote melanoma cell spreading and focal adhesion formation
69. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization
70. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro
71. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
72. Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1
73. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
74. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells
75. Association of thrombospondin of endothelial cells with other matrix proteins and cell attachment sites and migration tracks
76. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
77. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
78. Inhibition of angiogenesis by thrombospondin-2
79. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
80. Activated T-cell adhesion to thrombospondin is mediated by the α4β1 (VLA-4) and α5β1 (VLA-5) integrins
81. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions
82. Differential effects of the integrins α9β1, αvβ3, and αvβ6 on cell proliferative responses to tenascin